TrialDiabetes care2023

Once-Weekly Basal Insulin Fc Demonstrated Similar Glycemic Control to Once-Daily Insulin Degludec in Insulin-Naive Patients With Type 2 Diabetes: A Phase 2 Randomized Control Trial.

Juliana M Bue-Valleskey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.